(MedPage Today) — The FDA announced the launch of the first “real-time” clinical trial, with a second soon following, that will enable agency reviewers to see certain data signals immediately.
Both are cancer trials and considered proof-of-concept…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
